Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Observational Follow-up to ST-001 Calciphylaxis Pain Treatment With Intravenous Sodium Thiosulfate

Trial Profile

Observational Follow-up to ST-001 Calciphylaxis Pain Treatment With Intravenous Sodium Thiosulfate

Discontinued
Phase of Trial: Phase III

Latest Information Update: 26 Nov 2018

At a glance

  • Drugs Sodium thiosulfate (Primary)
  • Indications Calciphylaxis
  • Focus Adverse reactions; Registrational
  • Acronyms OF-CALISTA
  • Sponsors Hope Pharmaceuticals
  • Most Recent Events

    • 18 Nov 2018 Status changed from recruiting to discontinued.
    • 31 Oct 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top